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Altered Cell-surface Receptor Levels Result from Fructose Advanced Glycation
End Product-Induced Inflammation
Abstract
Objective: As a result of the heightened reactivity fructose demonstrates compared to glucose and our
current knowledge of glucose advanced glycation end-products, the aim of this research was to further
elucidate the proinflammatory pathways involved in the response to fru-AGE exposure, including the
effects of fru-AGEs on cell-surface receptor expression. We hypothesized that once microglia were
activated in response to fru-AGE exposure, there would be an increase in the expression of RAGE and
TLR4 to facilitate the proinflammatory cascade.
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RAGE Gene and Protein Expression
Figure 1: Effects of fru-AGEs on the gene transcription and protein levels of
RAGE. RAGE expression decreased significantly across all treatments after 3 hours of
exposure to fru-AGEs and there was still a downward trend after 24 hours (ANOVA p =
0.08) (1A) . RAGE protein levels also decreased after 24 hours of exposure to fruAGEs (1B, 1C, 1D, 1E). This included pre-processed, mature and the breakdown
product of RAGE. A representative Western blot image illustrates this same trend (1B).
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Figure 2: Effects of fru-AGEs on
the transcription of C5. After 3
hours of exposure to fru-AGEs,
there was no change in the
expression of C5, except an
increase in expression at 0.8
mcg/mcL. After 24 hours of
exposure
to
fru-AGEs,
C5
expression increased.
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Figure 3: Effects of fru-AGEs on
the transcription of IL-1β. After 3
hours of exposure to fru-AGEs, the
data suggests that there is a dosedependent
increase
in
the
transcription of IL-1β.
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Figure 5: Effects of fru-AGEs on the gene transcription of TLR4.
Exposure to fru-AGEs decreased the expression of TLR4 after 3 hours
of treatment. The graph above suggests at concentrations ≥ 0.2
mcg/mcL the decrease is more pronounced.
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Figure 4: Effects of fru-AGEs on
the gene transcription of TNFα.
After both 3 and 24 hours of
exposure
to
fru-AGEs,
the
expression of TNFα increases in a
dose dependent manner, which
was statistically significant at 0.8
mcg/mcL.
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Analysis of protein levels support the gene expression trend observed
with RAGE. Chronic exposure to fru-AGEs leads to a diminished level
of mature RAGE protein.
The decrease in receptor expression observed with both RAGE and
TLR suggests that microglia can become desensitized to noxious
stimuli. This observation is concerning because immune cells need to
remain sensitized to noxious stimuli to help protect and defend the host.
This research continues to illustrate and support the hypothesis that
excess exposure to fru-AGEs induces an inflammatory state mediated
by microglia within the brain and alters cell-surface receptors.
In addition to their neurodegenerative effects in disease states such as
Alzheimer’s disease, further investigation about the endogenous effects
of fru-AGES should be considered, especially as a result of its
accessibility from its use as an industrial sweetener.
Further areas of research include additional replicates of C5, IL-1β and
TLR gene expression and extracellular H2O2 production to further
validate this hypothesis.
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Cell-surface receptors including RAGE and TLR4 also demonstrate
changes in their gene expression when exposed to fru-AGEs. RAGE
expression was acute and chronically suppressed after exposure to fruAGEs. After 3 hours, TLR4 was also suppressed but more replicates
are needed.
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This evidence suggests that exposure to fru-AGEs increases the
expression of known mediators of inflammation, including the following:
C5, IL-1β, TNFα (statistically significant, dose-dependent acute and
chronic effects) and extracellular H2O2 (statistically significant dosedependent effects)
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Fru-AGEs were generated by incubating fructose with bovine serum
albumin at 37°C for 8 weeks.4 An immortalized rat microglial cell line
(HAPI) was treated with control media or fru-AGEs in vitro for 3 or 24
hours in the following concentrations: 0.1, 0.2, 0.4 or 0.8 mcg/mcL.
Gene expression of pro-inflammatory markers and cell-surface
receptors was measured using quantitative real-time polymerase chain
reaction (qRT-PCR). Genes investigated included the following:
complement 5 (C5), interleukin-1β (IL-1β), tumor necrosis factor α
(TNFα), receptor for AGE (RAGE) and toll-like receptor 4 (TLR4).
Levels of RAGE protein were measured after 24 hours of exposure to
fru-AGEs via Western Blot.5 To further characterize the
proinflammatory response, extracellular hydrogen peroxide (H2O2) was
quantified using the ROS-Glo H2O2 chemiluminescent assay
(Promega) following a 3 hour incubation with the fru-AGE treatments
listed above. Statistically significant changes for each measure were
determined using a one-way ANOVA with a Tukey post-hoc test; a pvalue < 0.05 was considered significant. All data are expressed as the
mean ± SEM.
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Objective
As a result of the heightened reactivity fructose demonstrates
compared to glucose and our current knowledge of glucose advanced
glycation end-products, the aim of this research was to further
elucidate the proinflammatory pathways involved in the response to
fru-AGE exposure, including the effects of fru-AGEs on cell-surface
receptor expression. We hypothesized that once microglia were
activated in response to fru-AGE exposure, there would be an increase
in the expression of RAGE and TLR4 to facilitate the proinflammatory
cascade.
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Fructose, a naturally occurring simple sugar, is also an industrial
sweetener that has become a mainstay in the American diet, notably in
sugar drinks.1 A consequence of excess fructose consumption is the
non-enzymatic generation of fructose advanced glycation end-products
(fru-AGE[s]). The non-enzymatic glycation with fructose is ten times
greater compared to glucose.2 Within the central nervous system,
microglia, residential macrophages surveying their microenvironment,
become activated when exposed to fru-AGEs. The activation of
microglia initiates a cascade of proinflammatory processes. Some of
the proinflammatory mediators released include: IL-1β, toll-like receptor
4 (TLR4), tumor necrosis factor α (TNFα) and reactive oxygen species
(e.g., H2O2). Current evidence suggests that activation of microglia is
mediated through the receptor for advanced glycation end-products
(RAGE).Although AGE formation is a natural process, the excess
exposure to AGEs has been implicated in the pathology of certain
diseases, including: diabetic microvascular complications3 (e.g.,
retinopathy, nephropathy) and age-related diseases, such as
Alzheimer's disease.
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Figure 6: Effects of fru-AGEs on the extracellular production of H2O2.
After 3 hours of exposure to fru-AGEs, the production of H2O2
significantly increased.
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